Table 3.

Impact, Stability and Control During Study Visits (V1 and V2) Among Study Participants According to Clinical or CAT Criteria

CAT Evaluation	V1	V2	Clinical Evaluation	V1	V2
Impact (CAT)			Clinical Impact
Low	60 (64.4%)	57 (61.3%)	Low	62 (66.7%)	68 (73.1%)
High	33 (35.5%)	36 (38.8%)	High	31 (33.4%)	25 (26.9%)
Stability (CAT)			Stability (Exacerbations)
Stable	73 (78.5%)	68 (73.1%)	Stable	68 (73.1%)	66(70.9%)
No	20 (21.6%)	25 (26.9%)	No	25 (26.9%)	27 (29.1%)
Control (CAT)			Control
Controlled	45 (48.4%)	50 (53.8%)	Controlled	52 (55.1%)	55 (59.2%)
Not controlled	48 (51.6%)	43 (46.2%)	Not controlled	41 (44.1%)	38 (40.8%)